SCHEMBL25004067

SCHEMBL25004067

Clc1cc(-c2ccccn2)nc(-c2ccccc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 3/20 0.58
CCR5 P51681 3/20 0.58
CCR8 P51685 3/20 0.58
LMNA P02545 5/20 0.54
SMN1; SMN2 Q16637 6/20 0.49
RAB9A P51151 6/20 0.49
NPC1 O15118 5/20 0.49
KDM4E B2RXH2 6/20 0.48
POLB P06746 2/20 0.48
METAP1 P53582 2/20 0.48
CYP1A2 P05177 1/20 0.48
BLM P54132 1/20 0.48
HIF1A Q16665 1/20 0.48
DOHH Q9BU89 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
TP53 P04637 5/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
HSP90AA1 P07900 2/20 0.47
ALPL P05186 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30168349 0.90 KDM4E (0.51) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL28481809 0.90 KDM4E (0.51) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL22542906 0.90 KDM4E (0.51) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL28329986 0.89 LMNA (0.50) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL30168334 0.89 LMNA (0.50) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL4490247 0.87 CCR1 (0.63) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL29545764 0.87 CCR1 (0.63) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL28190882 0.87 KDM4E (0.58) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL9487125 0.86 KDM4E (0.57) CCR1CCR5CCR8LMNASMN1; SMN2
SCHEMBL18698104 0.84 MEN1 (0.56) CCR1CCR5CCR8LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042871-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230042871-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CCR1 2377/4885CCR5 2967/4885CCR8 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.